Labcorp Holdings company profile
Company profile
Labcorp Holdings has 71,000 employees and is headquartered in Burlington, United States.
With roughly 71,000 employees, Labcorp Holdings provides laboratory services organized in two segments, Diagnostics Laboratories and Biopharma Laboratory Services. Its menu of tests runs from routine blood chemistry, urinalysis, thyroid and HbA1c testing to specialty gene-based and esoteric tests covering areas such as oncology, cardiovascular disease, infectious disease, women's health, diagnostic genetics and pharmacogenetics. It also offers employer and managed care wellness services, digital pathology tools, provider and payer platforms, a patient app for scheduling and test results, and a generative AI test selection tool. Its clients include medicare and medicaid programs, third-party payers, pharmaceutical, biotechnology and medical device companies, diagnostic companies and CROs, and it works with the Children's Hospital of Philadelphia on pediatric diagnostics.
In the fiscal year ended December 2025, revenue reached USD 14.0 billion, up 7.2% from the prior year, and net income was USD 876.5 million. Domestic operations accounted for 83.5% of revenue in the same year. The company was founded in 1971 and is headquartered in Burlington, North Carolina. Its shares also trade on other listings outside the United States.
Company facts
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Country
- United States
- Headquarters
- 531 South Spring Street, 27215, Burlington
- Employees
- 71,000
- Chief executive
- Adam Schechter
- Founded
- 1971
- Fiscal year
- January - December
- Listing
- LH · NYSE
- Indices
- S&P 500
- Currency
- USD
- ISIN
- US5049221055
- Website
- labcorp.com
Labcorp Holdings and its competitors
The most similar companies by business and size
| Company | Country | Market cap | Employees | Operating margin | P/E (trailing 12 months) |
|---|---|---|---|---|---|
| Labcorp HoldingsLH | United States | $29.81B | 71,000 | 11.2% | 30.1 |
| IlluminaILMN | United States | $29.15B | 8,600 | 19.1% | 33.2 |
| Quest DiagnosticsDGX | United States | $28.42B | 60,000 | 14.9% | 25.7 |
| Mettler-Toledo InternationalMTD | United States | $33.15B | 16,600 | 27.8% | 36.2 |
| NateraNTRA | United States | $39.64B | 6,135 | -8.5% | — |
| IQVIA HoldingsIQV | United States | $40.51B | 95,000 | 13.9% | 29.9 |
Competitors: same or related industry, same region first, then the closest market capitalization. Market cap converted into US dollars at the latest exchange rates; P/E over the last 12 months, not shown when negative.
